Why the study?
Do variables detected on CCTA predict plaque progression in non-culprit lesions in patients undergoing PCI?
Do variables detected on CCTA predict plaque progression in non-culprit lesions in patients undergoing PCI?
Noninvasive assessment of non-culprit lesions by CCTA has potential prognostic value for predicting plaque progression.
CCTA variables may flag high-risk non-culprit lesions post-PCI; leaves open need for prospective validation before clinical adoption.
OBJECTIVE: This study sought to determine whether variables detected on coronary computed tomography angiography (CCTA) would predict plaque progression in non-culprit lesions (NCL). MATERIALS AND METHODS: In this single-center trial, we analyzed 103 consecutive patients who were undergoing CCTA and percutaneous coronary intervention (PCI) for culprit lesions. Follow-up CCTA was scheduled 12 months after the PCI, and all patients were followed for 3 years after their second CCTA examination. High-risk plaque features and epicardial adipose tissue (EAT) volume were assessed by CCTA. Each NCL stenosis grade was compared visually between two CCTA scans to detect plaque progression, and patients were stratified into two groups based on this. Logistic regression analysis was used to evaluate the factors that were independently associated with plaque progression in NCLs. Time-to-event curves were compared using the log-rank statistic. RESULTS: = 0.006). CONCLUSION: Noninvasive assessment of NCLs by CCTA has potential prognostic value.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: